Suppr超能文献

心脏移植术后早期 presepsin、降钙素原和 C 反应蛋白的连续测量以及抗胸腺细胞球蛋白给药后的反应。

Serial measurement of presepsin, procalcitonin, and C-reactive protein in the early postoperative period and the response to antithymocyte globulin administration after heart transplantation.

作者信息

Franeková Janka, Sečník Peter, Lavríková Petra, Kubíček Zdenek, Hošková Lenka, Kieslichová Eva, Jabor Antonín

机构信息

Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Third Faculty of Medicine, Charles University, Prague, Czech Republic.

出版信息

Clin Transplant. 2017 Jan;31(1). doi: 10.1111/ctr.12870. Epub 2016 Dec 9.

Abstract

Differentiation between systemic inflammatory response syndrome and sepsis in surgical patients is of crucial significance. Procalcitonin (PCT) and C-reactive protein (CRP) are widely used biomarkers, but PCT becomes compromised after antithymocyte globulin (ATG) administration, and CRP exhibits limited specificity. Presepsin has been suggested as an alternative biomarker of sepsis. This study aimed to demonstrate the role of presepsin in patients after heart transplantation (HTx). Plasma presepsin, PCT, and CRP were measured in 107 patients serially for up to 10 days following HTx. Time responses of biomarkers were evaluated for both noninfected (n=91) and infected (n=16) patients. Areas under the concentration curve differed in the two groups of patients for presepsin (P<.001), PCT (P<.005), and CRP (P<.001). The effect of time and infection was significant for all three biomarkers (P<.05 all). In contrast to PCT, presepsin was not influenced by ATG administration. More than 25% of noninfected patients had PCT above 42 μg/L on the first day, and the peak concentration of CRP in infected patients was reached on the third post-transplant day (median 135 mg/L). Presepsin seems to be as valuable a biomarker as PCT or CRP in the evaluation of infectious complications in patients after HTx.

摘要

区分外科患者的全身炎症反应综合征和脓毒症具有至关重要的意义。降钙素原(PCT)和C反应蛋白(CRP)是广泛使用的生物标志物,但使用抗胸腺细胞球蛋白(ATG)后PCT会受到影响,而CRP的特异性有限。可溶性髓系细胞触发受体-1(Presepsin)已被提议作为脓毒症的替代生物标志物。本研究旨在证明Presepsin在心脏移植(HTx)术后患者中的作用。在107例患者HTx术后连续10天测量血浆Presepsin、PCT和CRP。对未感染(n = 91)和感染(n = 16)患者的生物标志物的时间反应进行了评估。两组患者的Presepsin(P <.001)、PCT(P <.005)和CRP(P <.001)的浓度曲线下面积存在差异。所有三种生物标志物的时间和感染效应均具有显著性(均P <.05)。与PCT不同,Presepsin不受ATG给药的影响。超过25%的未感染患者在第一天PCT高于42μg/L,感染患者的CRP峰值浓度在移植后第三天达到(中位数135mg/L)。在评估HTx术后患者的感染并发症方面,Presepsin似乎是与PCT或CRP一样有价值的生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验